Dr. Juliet M. Kral, MD

  • Stanford, CA
  • Hematologist and oncologist
NPI1225046188PAC ID4688853989
Medicare services, 2024
442
Medicare patients, 2024
172
Part D claims, 2024
402
Hospital affiliations
4
Industry payments
$1,404
Practice address
300 Pasteur Drive, Stanford, CA 94305
Practice phone
Call (650) 723-4000
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Stanford Hospital at 300 Pasteur Drive

Hospital · Stanford, California

See all 4 affiliations

Find Dr. Kral's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Juliet M. Kral is a hematologist and oncologist in Stanford, California

Dr. Kral practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University.

Dr. Kral's NPI, 1225046188, was assigned on August 4, 2006. Dr. Kral graduated from Keck School of Medicine of USC in 1990. Dr. Kral holds California license G072424.

NPI and contact details
Medicare PAC ID
4688853989
NPI enumeration date
August 4, 2006
NPI status
Active
Accepts Medicare assignment
Yes
Practice phone
(650) 723-4000
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Female
Estimated age
62
Medical school graduation
1990

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Juliet M. Kral practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California

Dr. Kral's primary practice is Stanford Hospital at 300 Pasteur Drive, at 300 Pasteur Drive, Stanford, CA 94305 in Santa Clara County. The practice phone is (650) 723-4000.

Source: Dmand AI Affiliation Data

Dr. Juliet M. Kral is affiliated with 4 sites of care

Dr. Kral's primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. Dr. Kral is also affiliated with Mills-Peninsula Medical Center. Dmand AI also links Dr. Kral to 2 more hospitals, each named with a free account.

See all 4 affiliations for Dr. Kral

Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data

Dmand AI tracks the EHR system at Dr. Juliet M. Kral's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kral practices, 4 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Stanford Hospital at 300 Pasteur DriveAvailable with a free account
+3 more affiliated sitesAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every hospital where Dr. Kral practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across Stanford University and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Juliet M. Kral is one of 1,502 hematologists and oncologists in California

Hematology and oncology is Dr. Kral's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Kral is board certified in medical oncology by the American Board of Internal Medicine. Dr. Kral is licensed in California.

Specialties and state licenses

  • Hematology and oncology, CaliforniaPrimaryLicense G072424 · 1991 to 2027 · taxonomy 207RH0003X

Clinical focus

Dmand AI lists breast cancer, chronic anemia and lymphoma among the conditions Dr. Kral treats.

Hematologists and oncologists near Dr. Kral

Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Juliet M. Kral billed Medicare for 442 services in 2024

CMS data shows 442 Medicare services from Dr. Kral across 5 procedure codes in 2024, for 172 Medicare patients. Medicare paid $41,624 for them. Every service was in an office.

Medicare services, 2024442
Medicare patients172
Paid by Medicare$41,624
Procedure codes5

Dr. Kral's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Office and hospital visits
2023: 4262024: 36415%
Surgery
2023: 1192024: 7834%

Dr. Kral compared with the California median for hematologists and oncologists, 2024

  • Dr. Kral
  • California median
Medicare services
442vs 93253% below
Medicare patients
172vs 22524% below
Part D claims
267vs 39432% below

Medians across 1,367 hematologists and oncologists in California with Dmand AI profiles that report each measure.

Dr. Kral's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Kral

Need commercial claims for Dr. Kral?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Kral and other hematologists and oncologists in California.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Juliet M. Kral treated 172 Medicare patients in 2024, average age 77

CMS counts 172 Medicare patients who saw Dr. Kral in 2024. The largest group is 75 to 84, with 77 patients. 75% of them have cancer, and 75% have high cholesterol. Their average risk score is 0.86, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Kral's median patient age at 65, with 89% women.

Medicare patients, 2024172
Average age77
Average risk score0.86

Dr. Kral's Medicare patients by age, 2024

CMS leaves out age groups with fewer than 11 patients.

Chronic conditions among Dr. Kral's Medicare patients, 2024

  1. Cancer75%
  2. High cholesterol75%
  3. High blood pressure49%
  4. Arthritis40%
  5. Osteoporosis35%
  6. Ischemic heart disease15%
  7. Anxiety14%
  8. Asthma12%

Share of Medicare patients with each condition. A patient can have several.

Dr. Kral's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 65

Patient panel by sex, all payers

  • Women89%
  • Men10%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Juliet M. Kral wrote 402 Medicare Part D claims in 2024

In 2024, Dr. Kral wrote 402 Medicare Part D claims for 80 patients. 88% of them were for generic drugs. CMS names the drug for 267 of them, across 10 drugs with 11 or more claims each, at $426,698 in total drug cost. In 2023, CMS named 227 claims across 8 drugs.

Part D claims, 2024402
Drugs named by CMS10
Total drug cost$426,698
Part D patients80

Dr. Kral's Part D claims by kind of drug, 2024

  • Generic352 claims88%
  • Brand-name50 claims12%

Dr. Kral's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 2272024: 26718%

Drugs named by CMS: 10 in 2024, 8 in 2023.

See all prescribing by Dr. Kral

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

How Dr. Juliet M. Kral takes part in Medicare

Dr. Kral accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Accepts Medicare assignment
Yes

Source: Doctors and Clinicians National Downloadable File (CMS)

For MedTech and pharma teams

Find hematologists and oncologists like Dr. Kral by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Juliet M. Kral received $1,404 in industry payments from 2016 to 2025

CMS Open Payments shows 20 general payments to Dr. Kral from 3 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. AstraZeneca Pharmaceuticals LP paid the most, $1,288.

General payments to Dr. Kral by program year, 2016 to 2025

General payments to Dr. Kral by kind, 2016 to 2025

$1.4Kin total
  • Food and beverage$1,39399%
  • Education$111%

Companies that paid Dr. Kral the most, 2016 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Kral

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Juliet M. Kral graduated from Keck School of Medicine of USC

Dr. Kral graduated from Keck School of Medicine of USC in 1990.

  1. Medical schoolKeck School of Medicine of USC
  2. Board certified in medical oncologyAmerican Board of Internal Medicine

Source: Dmand AI Professional Profile Data

Dr. Juliet M. Kral accepts plans from 4 insurance carriers

Dr. Kral is in network with 4 carriers, including United Healthcare, Blue Cross Blue Shield of Michigan and Blue Cross and Blue Shield of Kansas City. Medicare plans come from the most carriers, 2. Check the plan with the practice before a visit.

  • United Healthcare
  • Blue Cross Blue Shield of Michigan
  • Blue Cross and Blue Shield of Kansas City
  • CMS Medicare

Plan types Dr. Kral accepts, by number of carriers

  1. Medicare2
  2. POS2
  3. PPO2
  4. EPO1
  5. HMO1

Source: Dmand AI Insurance Network Data

Sources for Dr. Juliet M. Kral's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneDmand AI Affiliation Data
Primary practice, affiliations and health systemDmand AI Affiliation DataDmand AI Org Hierarchy Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Training, board certification and membershipsDmand AI Professional Profile Data
Insurance carriers and plan typesDmand AI Insurance Network Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Juliet M. Kral

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Juliet M. Kral's NPI number?

Dr. Juliet M. Kral's NPI number is 1225046188. It was assigned on August 4, 2006, and it is active in the NPI Registry.

What kind of doctor is Dr. Juliet M. Kral?

Dr. Juliet M. Kral is a hematologist and oncologist in Stanford, California. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).

Where does Dr. Juliet M. Kral practice?

Dr. Kral practices at 300 Pasteur Drive, Stanford, CA 94305. Dr. Kral's primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. Dmand AI also links Dr. Kral to 2 hospitals.

What is Dr. Juliet M. Kral's office phone number?

The practice phone on file for Dr. Kral is (650) 723-4000.

What is Dr. Juliet M. Kral's medical license number?

Dr. Kral holds California license G072424.

Which hospitals is Dr. Juliet M. Kral affiliated with?

Dr. Kral practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California. Dr. Kral is also affiliated with Mills-Peninsula Medical Center. Dmand AI links Dr. Kral to 2 more hospitals.

Does Dr. Juliet M. Kral accept Medicare?

Yes. CMS data shows Dr. Kral billed Medicare for 442 services in 2024, and Dr. Kral accepts Medicare assignment.

How many Medicare patients does Dr. Juliet M. Kral see?

CMS counts 172 Medicare patients who saw Dr. Kral in 2024, with an average age of 77.

Is Dr. Juliet M. Kral board certified?

Yes. Dr. Kral is board certified in medical oncology by the American Board of Internal Medicine.

What services does Dr. Juliet M. Kral bill to Medicare?

In 2024, Dr. Kral's most billed Medicare services were office visit, established patient (99214), surgery: heart and blood vessels (36415) and office visit, established patient (99212).

Show 5 more questionsShow fewer questions

Where did Dr. Juliet M. Kral go to medical school?

Dr. Kral graduated from Keck School of Medicine of USC in 1990.

What drugs does Dr. Juliet M. Kral prescribe most?

In 2024 Medicare Part D data, Dr. Kral's most prescribed drugs by claims were Anastrozole, Raloxifene HCl and Alendronate Sodium.

Has Dr. Juliet M. Kral received payments from drug or device companies?

CMS Open Payments shows $1,404 in general payments to Dr. Kral from 3 companies from 2016 to 2025. The largest total came from AstraZeneca Pharmaceuticals LP.

How long has Dr. Juliet M. Kral been practicing?

Dr. Kral graduated from medical school in 1990, 36 years ago.

What insurance does Dr. Juliet M. Kral accept?

Dr. Kral is in network with 4 carriers, including United Healthcare, Blue Cross Blue Shield of Michigan and Blue Cross and Blue Shield of Kansas City. Medicare plans come from the most carriers, 2. Check the plan with the practice before a visit.

Selling to hematology and oncology practices?

See hematologists and oncologists in California by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)